Asunaprevir with peginterferon-alfa and ribavirin in treatment-naive patients with genotype-1 or -4 chronic hepatitis C: SVR24 results from a randomized phase 2b study (AI447–016) - Bronowicki, J P; Ratziu, V; Gadano, A; Thuluvath, P J
Paper presented at: The 48th Annual Meeting of the European Association for Study of the Liver Amsterdam; April 24–28, 2013; Amsterdam, The Netherlands